Eli Lilly and Company (LLY)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	32,739,700	31,415,100	30,204,300	25,188,800	25,727,000	23,007,000	21,331,600	20,811,400	18,034,500	17,639,900	17,115,200	16,964,700	18,452,400	17,808,300	17,295,500	16,604,500	17,462,100	16,239,900	14,581,900	13,994,200
Total current liabilities	US$ in thousands	28,376,600	24,674,100	27,121,200	18,598,100	27,293,200	21,998,200	18,915,000	16,010,000	17,138,200	15,652,800	15,620,600	13,386,000	15,052,700	13,682,000	15,093,200	11,714,200	12,481,600	11,976,900	11,988,500	12,610,200
Current ratio		1.15	1.27	1.11	1.35	0.94	1.05	1.13	1.30	1.05	1.13	1.10	1.27	1.23	1.30	1.15	1.42	1.40	1.36	1.22	1.11

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $32,739,700K ÷ $28,376,600K
= 1.15

The current ratio of Eli Lilly and Company has shown variability over the quarters, ranging from 0.94 to 1.42. Generally, a current ratio above 1 indicates that the company has more current assets than current liabilities, which is considered a positive sign of liquidity.

The highest ratios were observed in the first quarter of 2021 and the first quarter of 2024, indicating strong liquidity positions during those periods. Conversely, the lowest ratios were recorded in the fourth quarter of 2023 and the first quarter of 2024, suggesting potential liquidity challenges or fluctuations in the company's current asset and liability mix.

Overall, the company's current ratio trend has shown some fluctuations but has generally stayed within a reasonable range, reflecting a balanced liquidity position. Further analysis of the company's current assets and liabilities composition could provide more insights into its short-term financial health.